Yahoo
NasdaqGM - Delayed Quote USD

Candel Therapeutics, Inc. (CADL)

12.85 -0.22 (-1.68%)
At close: 4:00:01 PM EDT
12.88 +0.03 (+0.23%)
After hours: 4:55:18 PM EDT
Trade CADL on Coinbase
Chart Range Bar
Loading chart for CADL

What's happening with CADL?

2m ago
Powered by Yahoo Scout

Candel Therapeutics is navigating significant challenges with a $38.91 million Q2 loss, yet it remains optimistic about upcoming milestones, including a Q4 2026 BLA submissionfor its prostate cancer treatment. Despite rising cash burn, retail sentiment is bullish, with shares nearly doubling year-to-date amid potential market opportunities.

Powered by Yahoo Scout
  • Previous Close 13.07
  • Open 12.93
  • Bid 7.49 x 200
  • Ask 13.51 x 200
  • Day's Range 12.60 - 13.03
  • 52 Week Range 4.35 - 14.00
  • Volume 935,599
  • Avg. Volume 1,621,027
  • Market Cap (intraday) 983.264M
  • Beta (5Y Monthly) -0.50
  • PE Ratio (TTM) --
  • EPS (TTM) -1.47
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 21.00

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

www.candeltx.com

55

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CADL
127.43%
S&P 500 (^GSPC)
11.48%

1-Year Return

CADL
121.93%
S&P 500 (^GSPC)
18.13%

3-Year Return

CADL
961.98%
S&P 500 (^GSPC)
69.00%

5-Year Return

CADL
61.23%
S&P 500 (^GSPC)
68.69%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -8.86M
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-20M
-10M
0
0.0%

Analyst Insights

View More

Top Analyst

HC Wainwright & Co.
60/100
Latest Rating
Buy

Analyst Price Targets

12.00
21.00 Average
12.85 Current
29.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst B of A Securities
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 9 -> 12

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    1.05B

  • Enterprise Value

    900.46M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    8.34

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -28.64%

  • Return on Equity (ttm)

    -81.84%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -88.53M

  • Diluted EPS (ttm)

    -1.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    201.56M

  • Total Debt/Equity (mrq)

    39.26%

  • Levered Free Cash Flow (ttm)

    -35.75M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

12.85 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 03/08/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/07/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/06/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/03/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: